Medical technology continues to lose ground when it comes to all U.S. venture capital investment as value-based care takes hold of the healthcare system and the industry fights to get rid of a device tax, a new report indicates.
The share of medical technology venture deals dropped to just 4% of total deals last year compared to the industry’s 13% share 25 years ago, according to the analysis by the Deloitte Center for Health Solutions and The Advanced Medical Technology Association (AdvaMed).
